Saturday 17 October 2026
Export CHE’s income statement to Excel — free account
Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024. In the quarter to June 2026, revenue grew 8.80%, EPS grew 42.8% and free cash flow fell 43.5%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years, revenue growth for three.
512.38
3.06
−0.59%
Follow CHE
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
24.38 | 40.42 | 22.13 | 31.92 | 26.59 | 30.83 | 30.32 | 32.31 | 26.33 | 23.19 |
Piotroski F-Score |
6 | 7 | 7 | 6 | 8 | 6 | 6 | 5 | 7 | 6 |
P/S ratio |
1.68 | 2.38 | 2.55 | 3.62 | 4.09 | 3.88 | 3.54 | 3.89 | 3.27 | 2.43 |
Altman Z-Score |
8.41 | 9.94 | 11.48 | 11.47 | 13.61 | 11.34 | 11.49 | 13.65 | 13.23 | 11.69 |
Altman Z″-Score (non-manufacturers) |
6.45 | 5.88 | 7.18 | 6.07 | 7.65 | 7.06 | 7.76 | 8.97 | 9.36 | 9.65 |
P/FCF ratio |
27.77 | 40.39 | 19.42 | 28.26 | 19.66 | 33.05 | 29.69 | 32.10 | 21.44 | 18.67 |
Beneish M-Score |
(2.42) | (2.96) | (2.77) | (2.59) | (3.22) | (2.67) | (2.58) | (2.33) | (2.78) | (2.76) |
P/Operating CF |
377.25 | (139.18) | 80.47 | 110.28 | 97.81 | 130.42 | 75.53 | 81.04 | 48.27 | 46.13 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 100 |
P/B ratio |
5.07 | 7.34 | 7.69 | 9.65 | 9.43 | 13.30 | 9.47 | 7.94 | 7.11 | 6.29 |
Price to Tangible BV |
0.00 | 461.03 | 363.62 | 306.70 | 41.55 | 0.00 | 64.30 | 20.34 | 22.11 | 26.83 |
EV/Sales |
1.74 | 2.43 | 2.60 | 3.69 | 4.07 | 3.97 | 3.56 | 3.81 | 3.24 | 2.45 |
EV/EBITDA |
12.74 | 26.97 | 16.39 | 23.60 | 18.97 | 21.11 | 18.84 | 21.49 | 18.34 | 15.34 |
EV/Operating CF |
20.31 | 24.96 | 16.17 | 23.73 | 17.31 | 27.52 | 24.50 | 26.15 | 18.89 | 15.94 |
EV/FCF |
28.75 | 41.30 | 19.82 | 28.79 | 19.60 | 33.86 | 29.78 | 31.52 | 21.24 | 18.75 |
Quick Ratio |
0.86 | 0.64 | 0.65 | 0.57 | 0.97 | 0.56 | 0.72 | 1.43 | 1.22 | 0.90 |
Current Ratio |
0.99 | 0.91 | 0.83 | 0.73 | 1.10 | 0.76 | 0.92 | 1.61 | 1.38 | 1.05 |
Net Debt/EBITDA |
0.43 | 0.60 | 0.35 | 0.44 | (0.06) | 0.50 | 0.06 | (0.66) | (0.41) | (0.18) |
Debt/Assets |
12.36% | 11.00% | 10.58% | 10.96% | 9.41% | 17.50% | 6.76% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.21 | 0.19 | 0.17 | 0.19 | 0.15 | 0.38 | 0.12 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.82 | 1.85 | 1.88 | 1.73 | 1.54 | 1.54 | 1.53 | 1.46 | 1.46 | 1.58 |
Operating CF/Net income |
1.25 | 1.66 | 1.40 | 1.37 | 1.53 | 1.15 | 1.24 | 1.21 | 1.38 | 1.46 |
Capex/Depreciation |
(1.07) | (1.72) | (1.33) | (1.16) | (1.00) | (0.97) | (0.92) | (0.91) | (0.73) | (0.89) |
Interest Coverage |
48.12 | 26.46 | 48.82 | 56.75 | 165.47 | 183.64 | 74.93 | 109.58 | 205.90 | 193.28 |
| 20.97% | 18.45% | 36.33% | 33.37% | 39.25% | 35.23% | 35.11% | 28.59% | 27.12% | 25.28% | |
| 12.55% | 10.91% | 21.69% | 19.60% | 23.64% | 19.34% | 17.93% | 17.52% | 18.10% | 16.54% | |
ROIC |
18.09% | 11.21% | 22.08% | 18.72% | 27.88% | 25.98% | 26.11% | 25.22% | 24.35% | 23.36% |
Return on Tangible Assets |
91.10% | 78.19% | 157.86% | 211.03% | 146.47% | 220.91% | 142.54% | 69.41% | 97.45% | 119.94% |
Average Days of Receivables |
30.56 | 24.89 | 24.47 | 27.08 | 22.26 | 23.41 | 23.83 | 29.26 | 25.70 | 26.34 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
15.45% | 16.60% | 15.21% | 15.77% | 15.88% | 17.14% | 16.80% | 17.45% | 17.45% | 16.49% |
Intangible Assets out of Total Assets |
0.60 | 0.58 | 0.59 | 0.55 | 0.49 | 0.51 | 0.47 | 0.40 | 0.45 | 0.49 |
Share Based Compensation of Revenue |
0.61% | 0.86% | 1.01% | 1.06% | 1.23% | 1.41% | 1.52% | 1.74% | 2.09% | 1.48% |
Graham Net Nets |
(0.07) | (0.05) | (0.05) | (0.05) | (0.02) | (0.06) | (0.05) | (0.01) | (0.02) | (0.04) |
Graham Number |
69.19 | 68.02 | 102.98 | 118.69 | 159.55 | 123.92 | 141.87 | 173.10 | 183.62 | 168.04 |
Earnings Yield |
4.10% | 2.47% | 4.52% | 3.13% | 3.76% | 3.24% | 3.30% | 3.09% | 3.80% | 4.31% |
Free Cash Flow Yield |
3.60% | 2.48% | 5.15% | 3.54% | 5.09% | 3.03% | 3.37% | 3.12% | 4.66% | 5.36% |
Revenue per Share |
96.25 | 103.80 | 111.01 | 121.39 | 130.34 | 136.51 | 143.01 | 150.46 | 161.83 | 175.72 |
Operating CF per Share |
8.26 | 10.12 | 17.88 | 18.86 | 30.67 | 19.69 | 20.76 | 21.95 | 27.79 | 26.97 |
Capex per Share |
(2.43) | (4.00) | (3.29) | (3.32) | (3.58) | (3.69) | (3.68) | (3.74) | (3.08) | (4.04) |
Free Cash Flow per Share |
5.84 | 6.12 | 14.59 | 15.54 | 27.09 | 16.01 | 17.07 | 18.21 | 24.71 | 22.92 |
Cash per Share |
0.93 | 0.69 | 0.30 | 0.39 | 10.20 | 2.10 | 4.97 | 17.54 | 11.87 | 5.18 |
Shareholders Equity per Share |
31.99 | 33.65 | 36.82 | 45.50 | 56.48 | 39.77 | 53.50 | 73.61 | 74.48 | 68.02 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
31.99 | 33.65 | 36.82 | 45.50 | 56.48 | 39.77 | 53.50 | 73.61 | 74.48 | 68.02 |
Free Cash Flow |
95.62 | 98.20 | 234.27 | 248.23 | 432.15 | 250.83 | 254.89 | 274.09 | 371.28 | 330.05 |
Working Capital |
(1.93) | (17.48) | (31.83) | (71.55) | 30.30 | (72.11) | (24.59) | 188.79 | 109.05 | 15.49 |
Capital Expenditures |
(39.77) | (64.30) | (52.87) | (53.02) | (57.14) | (57.77) | (54.99) | (56.21) | (46.22) | (58.23) |
Net Current Asset Value |
(186.06) | (203.63) | (224.35) | (351.04) | (204.31) | (489.16) | (370.68) | (59.38) | (154.83) | (256.17) |
EV/EBIT |
15.38 | 35.88 | 19.06 | 27.77 | 21.74 | 24.76 | 22.10 | 25.36 | 21.52 | 18.30 |
Capex to Sales |
0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
Price to Operating Income |
14.86 | 35.08 | 18.67 | 27.25 | 21.81 | 24.17 | 22.03 | 25.83 | 21.72 | 18.21 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.31 | 0.26 | 0.25 | 0.26 | 0.30 | 0.31 | 0.30 | 0.30 | 0.32 | 0.32 |
Cash ROIC |
14.75% | 15.05% | 33.50% | 28.47% | 36.05% | 28.15% | 26.27% | 19.98% | 28.62% | 31.32% |
Accounts Receivable Turnover |
13.24 | 13.57 | 15.29 | 14.72 | 15.37 | 16.20 | 15.44 | 14.11 | 13.79 | 14.30 |
Accounts Payable Turnover |
26.79 | 26.16 | 24.92 | 26.10 | 26.17 | 21.52 | 23.84 | 27.67 | 29.15 | 31.43 |
Inventory Turnover |
184.84 | 207.51 | 222.42 | 200.67 | 189.35 | 159.20 | 134.43 | 131.59 | 156.16 | 216.93 |
Average Days of Payables |
12.95 | 15.35 | 14.91 | 14.12 | 14.36 | 19.46 | 11.16 | 15.95 | 10.22 | 13.78 |
Days of Inventory on Hand |
1.88 | 1.69 | 1.70 | 2.06 | 1.88 | 2.69 | 2.74 | 2.99 | 1.90 | 1.61 |
Average Receivables |
119.14 | 122.84 | 116.58 | 131.67 | 135.34 | 132.04 | 138.31 | 160.46 | 176.34 | 176.87 |
Average Payables |
41.64 | 43.98 | 49.26 | 50.63 | 52.67 | 63.63 | 57.45 | 52.96 | 54.09 | 54.30 |
Average Inventory |
6.03 | 5.54 | 5.52 | 6.58 | 7.28 | 8.60 | 10.19 | 11.14 | 10.10 | 7.87 |
Average Assets |
866.19 | 900.04 | 947.78 | 1,121.92 | 1,351.61 | 1,388.82 | 1,392.37 | 1,555.05 | 1,668.34 | 1,603.38 |
Average Common Equity |
518.68 | 532.23 | 565.84 | 658.97 | 813.90 | 762.24 | 710.99 | 953.30 | 1,113.43 | 1,049.20 |
Columns are period end dates